Yes exercise, particularly resistance training, becomes even more important when using GLP-1 drugs
That pressure builds up quickly when medication slows digestion
If we dont act quickly to monitor and mitigate these risks, thousands more patients may suffer avoidable vision loss, often beginning with subtle symptoms like blurred or blurry vision that go unnoticed
So this is the kind of study that raises the question, okay, maybe there's something here, maybe not, but we have to do a higher-level study
FDA approval for Mounjaro as a weight loss medication expected soon
In sum, the GLP-1 phenomenon has reshaped pharma manufacturing strategy: it has accelerated vertical integration (Catalent deal), expanded global CDMO networks, and spurred forward-looking plant designs